Compass Therapeutics, Inc. logo

Compass Therapeutics, Inc.

NASDAQ:CMPX

Overview | Financials
Company Name Compass Therapeutics, Inc.
Symbol CMPX
Currency USD
Price 1.5
Market Cap 206,383,500
Dividend Yield 0%
52-week-range 0.765 - 2.34
Industry Biotechnology
Sector Healthcare
CEO Dr. Thomas J. Schuetz M.D., Ph.D.
Website https://www.compasstherapeutics.com

An error occurred while fetching data.

About Compass Therapeutics, Inc.

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical

Related Stocks

Mersana Therapeutics, Inc. logo

Mersana Therapeutics, Inc.

MRSN

1.62 USD

InterCure Ltd. logo

InterCure Ltd.

INCR

1.06 USD

Aerovate Therapeutics, Inc. logo

Aerovate Therapeutics, Inc.

AVTE

2.6 USD

Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

ANIK

16.33 USD

EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc.

EYPT

7.33 USD

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

3.69 USD

Utah Medical Products, Inc. logo

Utah Medical Products, Inc.

UTMD

61.43 USD

Financials

Numbers are in millions USD

Numbers are in millions USD